Literature DB >> 21354233

Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization.

Rickmer Braren1, Jennifer Altomonte, Marcus Settles, Frauke Neff, Irene Esposito, Oliver Ebert, Markus Schwaiger, Ernst Rummeny, Andreas Steingoetter.   

Abstract

BACKGROUND & AIMS: The hepatocellular carcinoma (HCC) exhibits varying degrees of vascularization with more poorly differentiated carcinoma commonly exhibiting high amounts of vascularization. Transcatheter arterial embolization (TAE) of HCC tumor nodules results in varying amounts of tumor necrosis. Reliable quantification of necrosis after TAE, would aid in treatment planning and testing of novel combinatorial treatment regimen. The aim of this work was to validate different imaging parameters as individual or combined predictors of tumor necrosis after TAE in an orthotopic rat HCC tumor model.
METHODS: Unifocal rat HCC was imaged by T(2)-weighted MRI, quantitative dynamic contrast enhanced (DCE) MRI, diffusion weighted MRI (DWI) and [(18)F]-FDG PET imaging before (day-1) and after (days 1 and 3) TAE. Univariate and multivariate regression analyses were carried out to analyze the ability of each imaging parameter to predict the percent residual vital tumor (vtu) and vital tissue (vti) as determined by quantitative histopathology.
RESULTS: TAE induced a wide range of tumor necrosis. Tumor volume was the only parameter showing a correlation with vti (r(2) = 0.63) before TAE. After TAE, moderate correlations were found for FDG tracer uptake (r(2) = 0.56) and plasma tissue transfer constant (r(2) = 0.55). Correlations were higher for the extravascular extracellular volume fraction (v(e), r(2) = 0.68) and highest for the apparent diffusion coefficient (ADC, r(2) = 0.86). Multivariate analyses confirmed highest correlation of ADC and v(e) with vtu and vti.
CONCLUSIONS: DWI and DCE-MRI with the respective parameters ADC (day 3) and v(e) (day 1) were identified as the most promising imaging techniques for the prediction of necrosis. This study validates a preclinical platform allowing for the improved tumor stratification after TAE and thus the testing of novel combinatorial therapy approaches in HCC.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21354233     DOI: 10.1016/j.jhep.2011.01.049

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  15 in total

Review 1.  Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Ke Yang; Xiao-Ming Zhang; Lin Yang; Hao Xu; Juan Peng
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

Review 2.  Prognostication and response assessment in liver and pancreatic tumors: The new imaging.

Authors:  Riccardo De Robertis; Paolo Tinazzi Martini; Emanuele Demozzi; Gino Puntel; Silvia Ortolani; Sara Cingarlini; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Claudio Bassi; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 3.  New paradigm for management of hepatocellular carcinoma by imaging.

Authors:  Ijin Joo; Byung Ihn Choi
Journal:  Liver Cancer       Date:  2012-09       Impact factor: 11.740

Review 4.  Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma.

Authors:  Jeong Min Lee; Jeong-Hee Yoon; Ijin Joo; Hyun Sik Woo
Journal:  Liver Cancer       Date:  2012-06       Impact factor: 11.740

5.  Kinetic analysis of FDG in rat liver: effect of dietary intervention on arterial and portal vein input.

Authors:  Sudheer D Rani; Samuel T Nemanich; Nicole Fettig; Kooresh I Shoghi
Journal:  Nucl Med Biol       Date:  2013-02-28       Impact factor: 2.408

Review 6.  Functional imaging techniques in hepatocellular carcinoma.

Authors:  V Goh; D Sarker; S Osmany; G J R Cook
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03-21       Impact factor: 10.057

Review 7.  Quantitative magnetic resonance imaging for focal liver lesions: bridging the gap between research and clinical practice.

Authors:  Roberto Cannella; Riccardo Sartoris; Jules Grégory; Lorenzo Garzelli; Valérie Vilgrain; Maxime Ronot; Marco Dioguardi Burgio
Journal:  Br J Radiol       Date:  2021-05-14       Impact factor: 3.629

8.  Experimental study of nasopharyngeal carcinoma radionuclide imaging and therapy using transferred human sodium/iodide symporter gene.

Authors:  Xing Zhong; Changzheng Shi; Jian Gong; Bin Guo; Mingzhu Li; Hao Xu
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

9.  Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation.

Authors:  Stephanie L Barnes; Jennifer G Whisenant; Mary E Loveless; Thomas E Yankeelov
Journal:  Pharmaceutics       Date:  2012       Impact factor: 6.321

10.  Multimodality multiparametric imaging of early tumor response to a novel antiangiogenic therapy based on anticalins.

Authors:  Reinhard Meier; Rickmer Braren; Yvonne Kosanke; Johanna Bussemer; Frauke Neff; Moritz Wildgruber; Sarah Schwarzenböck; Annette Frank; Bernhard Haller; Andreas M Hohlbaum; Markus Schwaiger; Hendrik Gille; Ernst J Rummeny; Ambros J Beer
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.